Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response.

Autor: Junghans, Richard P., Ma, Qiangzhong, Rathore, Ritesh, Gomes, Erica M., Bais, Anthony J., Lo, Agnes S.Y., Abedi, Mehrdad, Davies, Robin A., Cabral, Howard J., Al‐Homsi, A. Samer, Cohen, Stephen I.
Zdroj: Prostate; Oct2016, Vol. 76 Issue 14, p1257-1270, 14p
Databáze: Complementary Index